Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL

2.

Who Bears the Cost of "Forever Chemical" Cleanup?

3.

Regular physical activity before cancer diagnosis may lower progression and death risks

4.

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

5.

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot